Lazard Asset Management’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Buy
63,705
+386
+0.6% +$16K ﹤0.01% 807
2025
Q4
$2.94M Buy
63,319
+47,940
+312% +$2.31M 0.01% 725
2025
Q3
$755K Buy
+15,379
New +$804K ﹤0.01% 1232

Other funds holding HNGE

Lazard Asset Management's HNGE Position: Q1 2026 in Review

Lazard Asset Management increased its Hinge Health (HNGE) stake by 0.61% in Q1 2026, buying an estimated $16K and bringing the position to 63,705 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Lazard Asset Management first reported a position in HNGE in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.94M in Q4 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Lazard Asset Management held 63,705 shares of Hinge Health worth $2.46M as of Q1 2026.
  • Lazard Asset Management bought 386 Hinge Health shares in Q1 2026, an estimated $16K.
  • Hinge Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #807 holding.
  • Lazard Asset Management first reported a position in Hinge Health in Q3 2025 and has held it in 3 quarters since.
  • Lazard Asset Management's Hinge Health position peaked at $2.94M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.